An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 091001
Company: MYLAN

Products on ANDA 091001

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NISOLDIPINE	NISOLDIPINE	8.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No
NISOLDIPINE	NISOLDIPINE	17MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No
NISOLDIPINE	NISOLDIPINE	25.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	None	No	No
NISOLDIPINE	NISOLDIPINE	34MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 091001

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/26/2011	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/091001s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/11/2022	SUPPL-5	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 091001

NISOLDIPINE

TABLET, EXTENDED RELEASE;ORAL; 8.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NISOLDIPINE	NISOLDIPINE	8.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	091001	MYLAN
SULAR	NISOLDIPINE	8.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	020356	COVIS

TABLET, EXTENDED RELEASE;ORAL; 17MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NISOLDIPINE	NISOLDIPINE	17MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	091001	MYLAN
SULAR	NISOLDIPINE	17MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	020356	COVIS

TABLET, EXTENDED RELEASE;ORAL; 34MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
NISOLDIPINE	NISOLDIPINE	34MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	091001	MYLAN
SULAR	NISOLDIPINE	34MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	020356	COVIS

Top